Fundamental Research
Understanding basic biology and the cause of human disease
Translational Research
Advancing research to clinical breakthroughs for patients through drug discovery and collaborations
Education & Training
Cultivating the next generation of scientists through our graduate school, postdoctoral training programs and fellowships
The Latest News
-
Neuroscience and Aging
Machine learning’s next frontier: epigenetic drug discovery
Sanford Burnham Prebys scientists create a machine-learning algorithm that automates high-throughput screens of epigenetic medicines. -
Levin tours Institute to learn more about innovative biomedical research. -
Neuroscience and Aging
New insights into how to protect premature babies from common brain disorder
Sanford Burnham Prebys scientists identify a new cause of “water on the brain” involving receptors that disrupt fluid flow. -
Children's Health
Sanford Burnham Prebys scientist joins historic effort to help children with rare disease
The consortium is funded by a $5 million, five-year NIH grant and will address decades of unresolved questions. -
Institute honored for advances in understanding deadly pediatric brain tumors and colorectal cancer. -
Dr. Svasti Haricharan shares insights on how immunotherapy is working—and not working—for breast cancer. -
Experts discuss acute myeloid leukemia (AML) during the Sanford Burnham Prebys community lecture series. -
Learn about our new students and the bold projects they will undertake as part of our 2019 incoming class. -
Education
18th Annual Fishman Fund Award ceremony celebrates the next generation of biomedical trailblazers
Three talented early-career scientists were presented with prestigious Fishman Fund Awards on September 19 at the Sanford Consortium. -
Neuroscience and Aging
10 questions for Alzheimer’s expert Jerold Chun of Sanford Burnham Prebys
Chun weighs in on the state of Alzheimer’s research—and whether there is hope on the horizon. -
The collaborative projects aim to find new therapies for colorectal, lung, breast and prostate cancers. -
Knowing the structure of vitronectin enables rational drug design
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
AACR selects Sanford Burnham Prebys scientist as NextGen Star
The American Association for Cancer Research (AACR) has named Cosimo Commisso, Ph.D., assistant professor in our NCI-designated Cancer Center, as a NextGen Star.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
